Insider Transactions in Q3 2022 at Fate Therapeutics Inc (FATE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 18
2022
|
Edward J Dulac Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,135
-1.81%
|
$154,050
$30.08 P/Share
|
|
Jul 22
2022
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
6,246
-0.48%
|
$199,872
$32.41 P/Share
|
|
Jul 22
2022
|
J Scott Wolchko President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,246
+1.41%
|
$12,492
$2.7 P/Share
|
|
Jul 21
2022
|
J Scott Wolchko President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-3.3%
|
$960,000
$32.81 P/Share
|
|
Jul 21
2022
|
J Scott Wolchko President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.1%
|
$60,000
$2.7 P/Share
|
|
Jul 07
2022
|
Bahram Valamehr President and CEO |
SELL
Open market or private sale
|
Direct |
17,158
-8.71%
|
$514,740
$30.23 P/Share
|
|
Jul 07
2022
|
Bahram Valamehr President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,158
+8.01%
|
$34,316
$2.73 P/Share
|
|
Jul 06
2022
|
Bahram Valamehr President and CEO |
SELL
Open market or private sale
|
Direct |
7,842
-4.18%
|
$235,260
$30.07 P/Share
|
|
Jul 06
2022
|
Bahram Valamehr President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,842
+2.05%
|
$23,526
$3.79 P/Share
|
|
Jul 05
2022
|
Mark Plavsic Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
3,719
-2.84%
|
$89,256
$24.61 P/Share
|